Related Experiment Videos
[Malignant mesothelioma--a diagnostic challenge].
Maria João Marta1, João Santos Silva, Anabela Oliveira
1Interna do Complementar de Medicina Interna do Hospital de Santa Maria. Assistente Livre da Cadeira de Genética da Faculdade de Medicina de Lisboa.
Revista Portuguesa De Pneumologia
|June 10, 2004
Summary
Malignant mesothelioma, a rare cancer linked to asbestos exposure, presents diagnostic and treatment challenges. This case highlights the complexity of managing multiple neoplasms and poor prognosis, emphasizing the need for advanced therapies.
Area of Science:
- Oncology
- Pulmonology
- Occupational Medicine
Background:
- Malignant mesothelioma is a rare neoplasm strongly associated with asbestos exposure (80% of cases).
- It has a long latency period (20-50 years) and is often diagnosed at an advanced stage.
- Treatment is typically palliative due to resistance to chemotherapy and radiotherapy, with poor survival rates.
Observation:
- An 82-year-old ex-sailor with prostate cancer presented with cough and dyspnea.
- Chest radiograph revealed extensive right pleural effusion, prompting differential diagnoses including metastatic, infectious, and primitive neoplasms.
- Pleural biopsy confirmed epithelial malignant mesothelioma, linked to occupational asbestos exposure.
Findings:
- The patient had two concurrent malignant neoplasms, a rare clinical scenario.
- Epithelial malignant mesothelioma was diagnosed at Butchart stage II.
- Chemotherapy (gemcitabine and cisplatin) with pleurodesis was administered, leading to clinical improvement.
Implications:
- The co-existence of two distinct cancers, particularly mesothelioma, indicates a poor prognosis.
- This case underscores the importance of considering occupational exposures in cancer diagnosis.
- Further research into differential diagnostic techniques and targeted therapies for mesothelioma is warranted.